| NCT03078023 |
Sponge and Eosinophil Peroxidase (EPO) Staining |
https://ClinicalTrials.gov/show/NCT03078023 |
Recruiting |
Mayo Clinic |
2021-03-01 |
| NCT04322708 |
A Study of Antolimab (AK002) in Patients With Active Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT04322708 |
Recruiting |
Allakos, Inc. |
2021-12-31 |
| NCT03633617 |
Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT03633617 |
Recruiting |
Regeneron Pharmaceuticals |
2022-04-22 |
| NCT03553563 |
A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer |
https://ClinicalTrials.gov/show/NCT03553563 |
Recruiting |
AstraZeneca |
2023-01-04 |
| NCT01597674 |
Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01597674 |
Completed |
Trio Medicines Ltd. |
1997-06-30 |
| NCT03342391 |
CEGIR 7808: Use of Unsedated Transnasal Esophagoscopy (TNE) to Monitor Dietary Management of Eosinophilic Esophagitis in Children |
https://ClinicalTrials.gov/show/NCT03342391 |
Recruiting |
Children’s Hospital Medical Center, Cincinnati |
2020-07-31 |
| NCT03305653 |
Use of Esophageal String Test to Understand Symptoms, Inflammation, and Function in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT03305653 |
Recruiting |
University of Colorado, Denver |
2020-12-31 |
| NCT03228147 |
Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer Treatment |
https://ClinicalTrials.gov/show/NCT03228147 |
Completed |
Rutgers, The State University of New Jersey |
2017-10-31 |
| NCT03191864 |
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT03191864 |
Active, not recruiting |
Adare Pharmaceuticals, Inc. |
2019-11-08 |
| NCT03116841 |
Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory Evaluation |
https://ClinicalTrials.gov/show/NCT03116841 |
Completed |
Takeda |
2017-12-20 |
| NCT03029091 |
An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT03029091 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2019-07-22 |
| NCT03006874 |
Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT03006874 |
Completed |
CJ HealthCare Corporation |
2017-03-24 |
| NCT02881372 |
EoE Food Desensitization |
https://ClinicalTrials.gov/show/NCT02881372 |
Recruiting |
The University of Texas Health Science Center, Houston |
2020-05-31 |
| NCT02778867 |
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study |
https://ClinicalTrials.gov/show/NCT02778867 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2019-04-17 |
| NCT02755753 |
A Study to Evaluate REbamiPide as an Adjuvant Regimen to Heal erosIve Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT02755753 |
Completed |
Severance Hospital |
2016-01-31 |
| NCT02736409 |
An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT02736409 |
Completed |
Shire |
2019-11-04 |
| NCT02722148 |
Application of a Novel Allergen-Specific Immune Signature Directed Approach to Dietary Elimination Therapy in Patients With Eosinophilic Esophagitis (IDiET) |
https://ClinicalTrials.gov/show/NCT02722148 |
Completed |
University of North Carolina, Chapel Hill |
2018-04-30 |
| NCT02610816 |
Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids |
https://ClinicalTrials.gov/show/NCT02610816 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2018-05-16 |
| NCT02605837 |
A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is Achieved |
https://ClinicalTrials.gov/show/NCT02605837 |
Completed |
Shire |
2019-01-24 |
| NCT02599558 |
Cytosponge and Dietary Therapy in EoE |
https://ClinicalTrials.gov/show/NCT02599558 |
Recruiting |
Mayo Clinic |
2020-12-31 |
| NCT02577393 |
Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy |
https://ClinicalTrials.gov/show/NCT02577393 |
Enrolling by invitation |
Shandong Cancer Hospital and Institute |
2022-06-30 |
| NCT01733147 |
Modulation of Esophageal Inflammation in Barrett’s Esophagus by Omega-3 Fatty Acids |
https://ClinicalTrials.gov/show/NCT01733147 |
Active, not recruiting |
Mayo Clinic |
2021-01-31 |
| NCT03388047 |
Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett’s Oesophagus |
https://ClinicalTrials.gov/show/NCT03388047 |
Recruiting |
University of Cambridge |
2020-12-31 |
| NCT02028663 |
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT02028663 |
Completed |
CJ HealthCare Corporation |
2014-05-31 |
| NCT02513784 |
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome |
https://ClinicalTrials.gov/show/NCT02513784 |
Completed |
Columbia University |
2017-12-31 |
| NCT02493335 |
Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02493335 |
Active, not recruiting |
Dr. Falk Pharma GmbH |
2018-11-28 |
| NCT02463643 |
To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT02463643 |
Completed |
Zeria Pharmaceutical |
2016-10-31 |
| NCT02456935 |
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT02456935 |
Completed |
CJ HealthCare Corporation |
2016-07-31 |
| NCT02388724 |
Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT02388724 |
Completed |
Takeda |
2017-07-27 |
| NCT02379052 |
Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT02379052 |
Completed |
Regeneron Pharmaceuticals |
2017-02-17 |
| NCT02353078 |
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02353078 |
Completed |
Mayo Clinic |
2016-12-31 |
| NCT02280616 |
Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02280616 |
Completed |
Dr. Falk Pharma GmbH |
2013-04-30 |
| NCT02227836 |
Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02227836 |
Completed |
Mayo Clinic |
2017-09-30 |
| NCT02204150 |
Study to Image the Esophagus Using the OFDI Capsule |
https://ClinicalTrials.gov/show/NCT02204150 |
Completed |
Massachusetts General Hospital |
2015-07-31 |
| NCT02202590 |
Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus |
https://ClinicalTrials.gov/show/NCT02202590 |
Active, not recruiting |
Massachusetts General Hospital |
2021-12-31 |
| NCT02153398 |
A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases |
https://ClinicalTrials.gov/show/NCT02153398 |
Completed |
AstraZeneca |
2016-04-30 |
| NCT02141711 |
TAK-438 - Safety, Blood Levels & Effects of Repeated Doses |
https://ClinicalTrials.gov/show/NCT02141711 |
Completed |
Takeda |
2009-02-28 |
| NCT02125851 |
Comparison of Esophageal Clearance Times of Oral Budesonide Preparations |
https://ClinicalTrials.gov/show/NCT02125851 |
Completed |
Walter Reed National Military Medical Center |
2014-02-28 |
| NCT02098473 |
Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02098473 |
Completed |
Celgene |
2016-02-17 |
| NCT02096458 |
Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets |
https://ClinicalTrials.gov/show/NCT02096458 |
Completed |
Takeda |
2014-02-28 |
| NCT02038894 |
Comparing Anesthetic Techniques in Children Having Esophagogastroduodenoscopies |
https://ClinicalTrials.gov/show/NCT02038894 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2013-11-30 |
| NCT02019758 |
Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02019758 |
Completed |
University of North Carolina, Chapel Hill |
2018-05-31 |
| NCT01999439 |
EoE(Eosinophilic Esophagitis) |
https://ClinicalTrials.gov/show/NCT01999439 |
Completed |
University of Michigan |
2016-04-30 |
| NCT01964131 |
BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects |
https://ClinicalTrials.gov/show/NCT01964131 |
Completed |
AstraZeneca |
2013-12-31 |
| NCT01953575 |
Mucosal Impedance and Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01953575 |
Completed |
Mayo Clinic |
2019-06-10 |
| NCT01952847 |
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis |
https://ClinicalTrials.gov/show/NCT01952847 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT01874535 |
Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy |
https://ClinicalTrials.gov/show/NCT01874535 |
Completed |
Chang Gung Memorial Hospital |
2016-06-30 |
| NCT01860482 |
The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD |
https://ClinicalTrials.gov/show/NCT01860482 |
Completed |
Chong Kun Dang Pharmaceutical |
2015-05-31 |
| NCT01846962 |
Dietetic Versus Topical Steroids for Pediatric Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01846962 |
Completed |
Azienda Policlinico Umberto I |
2013-04-30 |
| NCT01733810 |
The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01733810 |
Completed |
Dallas VA Medical Center |
2015-07-31 |
| NCT01696734 |
Domperidone in Treating Patients With Gastrointestinal Disorders |
https://ClinicalTrials.gov/show/NCT01696734 |
Recruiting |
M.D. Anderson Cancer Center |
2021-10-31 |
| NCT01669811 |
Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus) |
https://ClinicalTrials.gov/show/NCT01669811 |
Completed |
AstraZeneca |
2014-05-31 |
| NCT01642615 |
Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents |
https://ClinicalTrials.gov/show/NCT01642615 |
Completed |
Takeda |
2014-11-30 |
| NCT01642212 |
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension |
https://ClinicalTrials.gov/show/NCT01642212 |
Completed |
Shire |
2014-10-30 |
| NCT01641913 |
Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients |
https://ClinicalTrials.gov/show/NCT01641913 |
Completed |
Mayo Clinic |
2014-01-31 |
| NCT01630746 |
A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT01630746 |
Completed |
Takeda |
2013-09-30 |
| NCT01599858 |
Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01599858 |
Completed |
Trio Medicines Ltd. |
1996-10-31 |
| NCT01585103 |
Cytosponge Protocol IRB 11-006429 |
https://ClinicalTrials.gov/show/NCT01585103 |
Recruiting |
Mayo Clinic |
2021-09-30 |
| NCT01538849 |
Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01538849 |
Completed |
Yuhan Corporation |
2013-11-30 |
| NCT01538797 |
Effect of Single Doses of YF476 on Stomach Acidity Compared With Ranitidine and Placebo in Fasted and Fed States |
https://ClinicalTrials.gov/show/NCT01538797 |
Completed |
Trio Medicines Ltd. |
1996-08-31 |
| NCT01538784 |
Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men |
https://ClinicalTrials.gov/show/NCT01538784 |
Completed |
Trio Medicines Ltd. |
1996-06-30 |
| NCT01509261 |
Efficacy Study of Ilaprazole to Treat Erosive Esophgitis |
https://ClinicalTrials.gov/show/NCT01509261 |
Completed |
Il-Yang Pharm. Co., Ltd. |
2011-06-30 |
| NCT01499368 |
A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients |
https://ClinicalTrials.gov/show/NCT01499368 |
Completed |
Boryung Pharmaceutical Co., Ltd |
2012-11-30 |
| NCT01459367 |
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT01459367 |
Completed |
Takeda |
2013-03-31 |
| NCT01452698 |
Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT01452698 |
Completed |
Takeda |
2012-08-31 |
| NCT01397084 |
To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole |
https://ClinicalTrials.gov/show/NCT01397084 |
Completed |
AstraZeneca |
2012-01-31 |
| NCT01386112 |
Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01386112 |
Completed |
Forest Laboratories |
2012-10-31 |
| NCT01381991 |
The Efficacy of i-Scan for Detecting Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01381991 |
Completed |
Konkuk University Hospital |
2010-11-30 |
| NCT04281108 |
Efficacy and Safety APT-1011 in Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2) |
https://ClinicalTrials.gov/show/NCT04281108 |
Recruiting |
Adare Pharmaceuticals, Inc. |
2021-10-31 |
| NCT04255693 |
Real-life Study of Changes of Gastroesophageal Reflux Disease Manifestations Due to Behavioural and Diet Adherence |
https://ClinicalTrials.gov/show/NCT04255693 |
Recruiting |
Federal State Budgetary Scientific Institution "Federal Research Centre of Nutrition, Biotechnology |
2023-12-31 |
| NCT04225026 |
Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis Due to Chemoradiotherapy for Lung Cancer |
https://ClinicalTrials.gov/show/NCT04225026 |
Recruiting |
Galera Therapeutics, Inc. |
2021-12-31 |
| NCT04171986 |
Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis |
https://ClinicalTrials.gov/show/NCT04171986 |
Recruiting |
Tianjin Medical University Cancer Institute and Hospital |
2021-10-31 |
| NCT04149470 |
Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE) |
https://ClinicalTrials.gov/show/NCT04149470 |
Recruiting |
University of Colorado, Denver |
2021-12-31 |
| NCT04124926 |
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT04124926 |
Recruiting |
Phathom Pharmaceuticals, Inc. |
2021-07-01 |
| NCT04070677 |
Clinical Study Assessing the Effect of ZIVEREL® in Cancer Patients |
https://ClinicalTrials.gov/show/NCT04070677 |
Recruiting |
Grupo de Investigación ClÃnica en OncologÃa Radioterapia |
2020-09-30 |
| NCT04069429 |
Radiation Dose in Humans From Orally Administered Tc99m-Heparin |
https://ClinicalTrials.gov/show/NCT04069429 |
Recruiting |
University of Utah |
2020-12-31 |
| NCT03245840 |
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT03245840 |
Active, not recruiting |
Shire |
2021-08-31 |
| NCT04022096 |
Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT04022096 |
Recruiting |
CJ HealthCare Corporation |
2020-12-31 |
| NCT03781596 |
EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone |
https://ClinicalTrials.gov/show/NCT03781596 |
Recruiting |
Walter Reed National Military Medical Center |
2020-10-02 |
| NCT03736369 |
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) |
https://ClinicalTrials.gov/show/NCT03736369 |
Completed |
Daewoong Pharmaceutical Co. LTD. |
2019-08-07 |
| NCT03657771 |
A Food Additive Removal Diet for Pediatric Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT03657771 |
Recruiting |
Nemours Children’s Clinic |
2020-09-30 |
| NCT03656380 |
Mepo for EoE Study |
https://ClinicalTrials.gov/show/NCT03656380 |
Recruiting |
University of North Carolina, Chapel Hill |
2020-12-31 |
| NCT03446118 |
MRI to Assess Fibrosis in Eosinophilic Esophagitis Patients |
https://ClinicalTrials.gov/show/NCT03446118 |
Recruiting |
Mayo Clinic |
2021-01-15 |
| NCT03415451 |
Explore the Efficiency of Fiberscope-guided Nasogastric Tube Insertion |
https://ClinicalTrials.gov/show/NCT03415451 |
Completed |
National Taiwan University Hospital |
2018-07-30 |
| NCT01262560 |
Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer |
https://ClinicalTrials.gov/show/NCT01262560 |
Completed |
Radiation Therapy Oncology Group |
2014-02-28 |
| NCT01093755 |
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett’s Esophagus Following Ablation? |
https://ClinicalTrials.gov/show/NCT01093755 |
Completed |
Mayo Clinic |
2014-11-30 |
| NCT01056783 |
Proof of Concept Study of OC000459 in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01056783 |
Completed |
Oxagen Ltd |
2011-06-30 |
| NCT01040598 |
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model |
https://ClinicalTrials.gov/show/NCT01040598 |
Completed |
O & O Alpan LLC |
2011-12-31 |
| NCT01022970 |
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01022970 |
Completed |
Novartis |
2012-02-29 |
| NCT01016223 |
A Randomized Double Blind Placebo Controlled Study of the Effect of Swallowed Beclomethasone Dipropionate on Inflammatory Markers in Adult Patients With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT01016223 |
Completed |
Penn State University |
2012-07-31 |
| NCT01008696 |
An Efficacy Study to Compare the Treatment Effects of Rabeprazole and Lansoprazole Depending on the Genotyping of CYP2C19 in Treating Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT01008696 |
Completed |
Janssen Korea, Ltd., Korea |
2008-08-31 |
| NCT00961233 |
Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE) |
https://ClinicalTrials.gov/show/NCT00961233 |
Completed |
University of North Carolina, Chapel Hill |
2011-08-31 |
| NCT00895817 |
Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00895817 |
Completed |
Walter Reed Army Medical Center |
2010-10-31 |
| NCT00880906 |
Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00880906 |
Completed |
Vanderbilt University Medical Center |
2013-12-31 |
| NCT00872755 |
Nissen and Gastroplasty in Gastroesophageal Reflux Disease (GERD) |
https://ClinicalTrials.gov/show/NCT00872755 |
Completed |
G. Hatzikosta General Hospital |
2008-04-30 |
| NCT03615677 |
Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT03615677 |
Completed |
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. |
2019-10-18 |
| NCT02995239 |
A Study to Compare the Pharmacokinetic Characteristics of CJ-12420 |
https://ClinicalTrials.gov/show/NCT02995239 |
Completed |
CJ HealthCare Corporation |
2015-04-30 |
| NCT02679508 |
Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term Safety |
https://ClinicalTrials.gov/show/NCT02679508 |
Active, not recruiting |
Takeda |
2022-02-28 |
| NCT02579876 |
Milk Patch for Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02579876 |
Completed |
Children’s Hospital of Philadelphia |
2017-12-20 |
| NCT02434029 |
Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02434029 |
Completed |
Dr. Falk Pharma GmbH |
2016-08-04 |
| NCT02388737 |
Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT02388737 |
Completed |
Takeda |
2018-12-24 |
| NCT02371941 |
Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT02371941 |
Completed |
University of Tennessee |
2017-07-31 |
| NCT01452776 |
Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT01452776 |
Completed |
Takeda |
2013-07-31 |
| NCT04252144 |
Study of Dietary Patterns and Food Diversity in Russian GERD Patients |
https://ClinicalTrials.gov/show/NCT04252144 |
Recruiting |
Russian Academy of Medical Sciences |
2022-09-30 |
| NCT00770913 |
Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis |
https://ClinicalTrials.gov/show/NCT00770913 |
Completed |
Eisai Inc. |
2009-11-30 |
| NCT00762073 |
Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00762073 |
Completed |
Shire |
2010-04-30 |
| NCT00728481 |
The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00728481 |
Completed |
Mayo Clinic |
2010-12-31 |
| NCT02100189 |
Esophageal Cytology With FISH in Detecting Esophageal Cancer |
https://ClinicalTrials.gov/show/NCT02100189 |
Completed |
OHSU Knight Cancer Institute |
2015-12-31 |
| NCT00693225 |
Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study |
https://ClinicalTrials.gov/show/NCT00693225 |
Completed |
Mayo Clinic |
2010-12-31 |
| NCT00644735 |
Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed |
https://ClinicalTrials.gov/show/NCT00644735 |
Completed |
AstraZeneca |
2004-01-31 |
| NCT00641602 |
A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00641602 |
Completed |
AstraZeneca |
2003-08-31 |
| NCT00638456 |
Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00638456 |
Completed |
University of California, San Diego |
2009-09-30 |
| NCT00635089 |
Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00635089 |
Completed |
Teva Pharmaceutical Industries |
2012-01-31 |
| NCT00634114 |
Reflux Esophagitis Phase III Study (Maintenance Treatment) |
https://ClinicalTrials.gov/show/NCT00634114 |
Completed |
AstraZeneca |
NA |
| NCT00633932 |
Reflux Esophagitis Phase III Study (Initial Treatment) |
https://ClinicalTrials.gov/show/NCT00633932 |
Completed |
AstraZeneca |
NA |
| NCT00538434 |
Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years |
https://ClinicalTrials.gov/show/NCT00538434 |
Completed |
Teva Pharmaceutical Industries |
2009-10-31 |
| NCT00523354 |
Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00523354 |
Completed |
Swiss EE Study Group |
2007-09-30 |
| NCT00511316 |
Trial of Montelukast in Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00511316 |
Completed |
Mayo Clinic |
2015-09-30 |
| NCT00471094 |
Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00471094 |
Completed |
Takeda |
2007-10-31 |
| NCT00426283 |
A Study of Flovent in Patients With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00426283 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2013-01-31 |
| NCT00358449 |
Intravenous Mepolizumab In Children With Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00358449 |
Completed |
GlaxoSmithKline |
2008-11-25 |
| NCT00321737 |
Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00321737 |
Completed |
Takeda |
2007-05-31 |
| NCT00284908 |
Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT00284908 |
Completed |
STEBA France |
2006-11-30 |
| NCT00275561 |
Topical Steroid Treatment for Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00275561 |
Completed |
Mayo Clinic |
2010-04-30 |
| NCT00274703 |
An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients |
https://ClinicalTrials.gov/show/NCT00274703 |
Completed |
GlaxoSmithKline |
2007-03-31 |
| NCT00271349 |
Budesonide for Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00271349 |
Completed |
Swiss EE Study Group |
2008-07-31 |
| NCT00266578 |
A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders |
https://ClinicalTrials.gov/show/NCT00266578 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2006-11-30 |
| NCT00266565 |
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome |
https://ClinicalTrials.gov/show/NCT00266565 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2012-07-31 |
| NCT00256737 |
Sopran - Omeprazole Treatment Versus Surgery |
https://ClinicalTrials.gov/show/NCT00256737 |
Completed |
AstraZeneca |
2005-10-31 |
| NCT00255164 |
Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00255164 |
Completed |
Takeda |
2006-11-30 |
| NCT00255151 |
Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00255151 |
Completed |
Takeda |
2006-11-30 |
| NCT00251719 |
Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00251719 |
Completed |
Takeda |
2007-01-31 |
| NCT00251693 |
Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00251693 |
Completed |
Takeda |
2007-01-31 |
| NCT00229424 |
Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - |
https://ClinicalTrials.gov/show/NCT00229424 |
Completed |
Taiho Pharmaceutical Co., Ltd. |
2006-10-31 |
| NCT00228527 |
Esomeprazole for Treatment of GERD in Pediatric Patients |
https://ClinicalTrials.gov/show/NCT00228527 |
Completed |
AstraZeneca |
NA |
| NCT00206284 |
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis. |
https://ClinicalTrials.gov/show/NCT00206284 |
Completed |
AstraZeneca |
NA |
| NCT00206245 |
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis. |
https://ClinicalTrials.gov/show/NCT00206245 |
Completed |
AstraZeneca |
NA |
| NCT00206180 |
NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00206180 |
Completed |
AstraZeneca |
NA |
| NCT00195208 |
Study Comparing a Pantoprazole Formulation to the Currently Marketed Tablet for GERD and Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00195208 |
Completed |
Wyeth is now a wholly owned subsidiary of Pfizer |
2005-11-30 |
| NCT00175045 |
Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00175045 |
Completed |
Takeda |
2003-10-31 |
| NCT00133770 |
Intravenous (IV) Pantoprazole in Erosive Esophagitis |
https://ClinicalTrials.gov/show/NCT00133770 |
Completed |
Emory University |
2006-07-31 |
| NCT00123656 |
Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis |
https://ClinicalTrials.gov/show/NCT00123656 |
Completed |
University of Utah |
2006-12-31 |
| NCT00123630 |
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab |
https://ClinicalTrials.gov/show/NCT00123630 |
Completed |
University of Utah |
2010-01-31 |
| NCT00081315 |
Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT00081315 |
Completed |
MedImmune LLC |
NA |
| NCT00005921 |
A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis |
https://ClinicalTrials.gov/show/NCT00005921 |
Completed |
NIH AIDS Clinical Trials Information Service |
NA |
| NCT00002041 |
Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients |
https://ClinicalTrials.gov/show/NCT00002041 |
Completed |
Bristol-Myers Squibb |
NA |